Problems with the CIs
A panel of experts of the Central Drugs Authority has reviewed the data of the Phase 3 study of Covaxin. Covaxin is developed through Bharat Biotech as well as the committee has endorsed the findings. Bharat Biotech Hyderabad has revealed the final analysis of Covaxin's efficiency rate during the 3rd stage of clinical research. On the 2-nd June 2021 Bharat Biotech told that the overall efficacy for Covaxin will be 77.8 percent against symptomatic infections. Bharat Biotech Phase 3 results Bharat Biotech has published their Phase 2 results of the tests they conducted with Covaxin. The company has presented the results to an expert panel and their findings have been accepted in the report by the committee. This article will give you all you should be aware of Bharat Biotech Covaxin's Stage III clinical trials. His most current tweet, on 2 2nd July, the co-founder the nation said that they were extremely proud of the researc...